Cure of colon cancer metastasis in rats with the new lipid A OM 174. Apoptosis of tumor cells and immunization of rats

Clinical and Experimental Metastasis

Volumn 17, Issue 4, 1999, Pages 299-306

  Onier, Nathalie ^a   Hilpert, Sophie ^a   Arnould, Laurent ^b   Saint Giorgio, Valérie ^a   Gwynfor Davies, J ^c   Bauer, Jacques ^c   Jeannin, Jean François ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b CENTRE GEORGES FRANÇOIS LECLERC   (France)

^c OM PHARMA   (Switzerland)

Author keywords

Apoptosis; Cancer immunotherapy; Immunization; In vivo; Lipid A

Indexed keywords

LIPID A DERIVATIVE; OM 174; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER REGRESSION; COLON CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; NONHUMAN; PHAGOCYTOSIS; RAT; TUMOR CELL; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CANCER VACCINES; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LIPOPOLYSACCHARIDES; MALE; NEOPLASM METASTASIS; RATS; REPRODUCIBILITY OF RESULTS;

EID: 0032884951     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006663017149     Document Type: Article

References (32)

1. Deidier A. Deux dissertations médicinales et chirurgicales, l'une sur la maladie vénérienne, l'autre sur la nature et la curation des lumeurs. Paris: C. M. D'Houry, imprimeur, 1725.
2. Coley WB. The treatment of inoperable sarcoma with the mixed toxins of crysipelas and bacillus prodigiosus. Am Med Assoc 1898; 31: 389-95.
3. Shear MJ, Turrner FC. Chemical treatment of tumor. V. Isolation of the hemorrhage-producing fraction from Serratia marcescens (Bacillus prodigiosus) culture filtrate. J Natl Cancer Inst 1943; 4: 81-97.
4. Engelhard R, Mackensen A, Galanos C, Andreesen R. Biological response to intravenously administered endotoxin in patients with advanced cancer. J Biol Resp Modif 1990; 9: 480-91.
5. Goto S, Sakai S, Kera J et al. Intradermal administration of lipopolysaccharide in treatment of human cancer. Cancer Immunol Immunother 1996; 42: 255-61.
6. Nowotny A. In search of the active sites in endotoxins. In Nowotny A (ed): Beneficial Effects of Endotoxins. New York: Plenum Press 1983; 1-56.
7. Jeannin JF, Onier N, Lagadec P et al. Antitumor effect of synthetic derivatives of Lipid A in an experimental model of colon cancer in the rat. Gastroenterology 1991; 101: 726-33.
8. Galanos C, Lehmann V, Luderritiz O. et al. Endotoxic properties of chemically synthetized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A. Eur J Biochem 1984; 140: 221-7.
9. Imoto M, Kusumoto S, Shiba T et al. Chemical structure of E. coli lipid A. Tetrahedron Lett 1985; 26: 907-8.
10. Martin F, Caignard A, Jeannin JF et al. Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int J Cancer 1983; 32: 623-7.
11. Lagadec P, Jeannin JF, Reisser D et al. Treatment with endotoxins of peritoneal carcinomatosis induced by colon tumor cells in the rat. Invas Metast 1987; 7: 83-95.
12. Blondiau C, Lagadec P, Lejeune P et al. Correlation between the capacity to activate macrophages in vitro and the antitutmor activity in vivo of lipopolysaccharides from different bacterial species. Immunobiol 1994; 190: 243-54.
13. Ribi E, Amano K, Cantrell J et al. Preparation and antitumor activity of nontoxic lipid A. Cancer Immunol Immunother 1982; 12: 91-6.
14. Qureshi N, Takayama K, Ribi F. Purification and structural determination of nontoxic lipid A obtained from the lipopolysaceharide of Salmonella typhimurium. J Biol Chem 1982; 257:11808-15.
15. Kumazawa E, Togho A, Soga T et al. Significant antitumor effect of a synthetic lipid A analogue, DT-5461, on murine syngeneic tumor models. Cancer Immunol Immunother 1992; 35: 307-14.
16. Sato K, Yoo YC, Mochizuki M et al. Inhibition of tumor-induced angiogenesis by a synthetic lipid A analogue with low endotoxicity, DT-5461. Jpn J Cancer Res 1995; 86: 374-82.
17. Jimbo T, Akimoto T, Tohgo A. Systemic administration of a synthetic lipid A derivative, DT-5461a, reduces tumor blood flow through endogenous TNF production in hepatic cancer model of VX2 carcinoma in rabbits. Anticancer Res 1996; 16: 359-64.
18. Nakatsuka M, Kumazawa Y, Ikeda S et al. Antitumor and antimicrobial activities of lipid A-subunit analogue GLA-27. J Clin Lab Immunol 1988; 26: 43-7.
19. Nakatsuka M, Kumazawa Y, Homma JY et al. Inhibition in mice of experimental metastasis of B16 melanoma by the synthetic Lipid A-subunit analog GLA-60. Int J Immunopharmacol 1991; 13: 11-9.
20. Yang D, Satoh M, Ueda H et al. Activation of tumor-infiltrating macrophages by a Synthetic lipid A analog (ONO-4007) and its implication in antitumor effects. Cancer Immunol Immunother 1994; 38: 287-93.
21. Matsumoto N, Aze Y, Akimoto A, Fujita T. Restoration of immune responses in tumor-bearing mice by ONO-4007, an antitumor lipid A derivative. Immunopharmacology 1997; 36: 69-78.
22. Kuramitsu Y, Noshibe M, Ohiro Y et al. A new synthetic lipid A analog, ONO-4007, stimulates the production of tumor necrosis factor-α in tumor tissues, resulting in the rejection of transplanted rat hepatoma cells. Anti-Cancer Drugs 1997; 8: 500-8.
23. Saiki I, Sato K, Yoo YC et al. Inhibition of tumor-induced angiogenesis by the administration of recombinant interferon-γ followed by a synthetic lipid-A subunit analogue (GLA-60). Int J Cancer 1992; 51: 641-5.
24. Jimbo T, Akimoto T, Tohgo A. Effect of combined administration of a synthetic low-toxicity lipid A derivative, DT 5461a, and indomethacin in various experimental tumor models of colon 26 carcinoma in mice. Cancer Immunol Immunother 1995; 40:10-6.
25. Boisteau O, Gautier F, Cordel S et al. Apoptosis induced by sodium butyrate treatment increases immunogenicity of rat colon tumor cell line. Apoptosis 1997; 2: 403-12.
26. Jeannin JF, Lagadec P, Pelletier D et al. Regression induced by lentinan of peritoneal carcinomatosis in a model of Colon Cancer in rat. Int J Immunopharmacol 1988: 10: 855-61.
27. Lejeune P, Reisser D, Onier N et al. Interleukin-8 has antitumor effects in rat which are not associated with PMN cytotoxicity. Cancer Immunol Immunother 1994: 38: 167-70.
28. Chauffert B, Dimanche-Boitrel MT, Genne P et al. Chimiothérapic expérimentale d'une carcinomatose péritonéale d'origine colique chez le rat. Gastroen Clin Biol 1992; 16: 215-9.
29. Akimoto T, Kumazawa E, Jimbo T et al. Antitumor effect of DT-5641a, a synthetic low-toxicity lipid A analog, involves endogenous tumor necrosis factor induction subsequent to macrophage activation. Int J Immunopharmacol 1994; 16: 887-93.
30. Casciola-Rosen LA, Anhalt GJ, Rosen A. DNA-dependent-protein kinase is one of a subset of autoanigens specifically eleaved early during apoptosis. J Exp Med 1995; 182: 1625-34.
31. Bonnotte B, Favre N, Moutet M et al. Bel-2-mediated inhibition of apoptosis prevents immunogenicity and restores tumorigenicity of spontaneously regressive tumors. J Immunol 1998, 161: 1433-38.
32. Onier N, Hilpert S, Reveneau S et al. Expression of inducible nitric oxide synthase in tumors in relation with their regression induced by a lipid A in rats. Int J Cancer 1999 (in press).